Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick F Fogarty

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Managed Care & Specialty Pharmacy|January 25, 2018
Real-World Analysis of Dispensed IUs of Coagulation Factor IX and Resultant Expenditures in Hemophilia B Patients Receiving Standard Half-Life Versus Extended Half-Life Products and Those Switching from Standard Half-Life to Extended Half-Life ProductsBartholomew J Tortella, José Alvir, Margaret McDonald, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 2, 2017
Revascularization strategies and in-hospital management in acute coronary syndromes complicated by hemophilia A or hemophilia BMatthew J Reilley, Anne Blair, William H Matthai, et al.
Managed Care (Langhorne, Pa.)|October 13, 2018
Real-World Analysis of Dispensed International Units of Coagulation Factor VIII and Resultant Expenditures for Hemophilia A Patients: A Comparison Between Standard Half-Life and Extended Half-Life ProductsAmit Chhabra, Patrick F Fogarty, Bartholomew J Tortella, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 22, 2024
Multiyear, real-world, retrospective cohort study using a patient-centric approach to evaluate the burden of haemophilia B in the United StatesArianna Burton, Yong Chen, Priya Patel, et al.
Lancet (London, England)|November 25, 2003
Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNAPatrick F Fogarty, Hiroki Yamaguchi, Adrian Wiestner, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 10, 2020
Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and BAmit Chhabra, Dean Spurden, Patrick F Fogarty, et al.
Blood|October 24, 2002
High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopeniaRichard D Huhn, Patrick F Fogarty, Ryotaro Nakamura, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 6, 2006
Venous thromboembolic disease. Clinical practice guidelines in oncologyLawrence D Wagman, Melissa F Baird, Charles L Bennett, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 18, 2008
Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncologyLawrence D Wagman, Melissa F Baird, Charles L Bennett, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 1, 2011
Venous thromboembolic diseaseMichael B Streiff, Paula L Bockenstedt, Spero R Cataland, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Managed Care & Specialty Pharmacy|January 25, 2018
Real-World Analysis of Dispensed IUs of Coagulation Factor IX and Resultant Expenditures in Hemophilia B Patients Receiving Standard Half-Life Versus Extended Half-Life Products and Those Switching from Standard Half-Life to Extended Half-Life ProductsBartholomew J Tortella, José Alvir, Margaret McDonald, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 2, 2017
Revascularization strategies and in-hospital management in acute coronary syndromes complicated by hemophilia A or hemophilia BMatthew J Reilley, Anne Blair, William H Matthai, et al.
Managed Care (Langhorne, Pa.)|October 13, 2018
Real-World Analysis of Dispensed International Units of Coagulation Factor VIII and Resultant Expenditures for Hemophilia A Patients: A Comparison Between Standard Half-Life and Extended Half-Life ProductsAmit Chhabra, Patrick F Fogarty, Bartholomew J Tortella, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 22, 2024
Multiyear, real-world, retrospective cohort study using a patient-centric approach to evaluate the burden of haemophilia B in the United StatesArianna Burton, Yong Chen, Priya Patel, et al.
Lancet (London, England)|November 25, 2003
Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNAPatrick F Fogarty, Hiroki Yamaguchi, Adrian Wiestner, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 10, 2020
Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and BAmit Chhabra, Dean Spurden, Patrick F Fogarty, et al.
Blood|October 24, 2002
High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopeniaRichard D Huhn, Patrick F Fogarty, Ryotaro Nakamura, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 6, 2006
Venous thromboembolic disease. Clinical practice guidelines in oncologyLawrence D Wagman, Melissa F Baird, Charles L Bennett, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 18, 2008
Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncologyLawrence D Wagman, Melissa F Baird, Charles L Bennett, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 1, 2011
Venous thromboembolic diseaseMichael B Streiff, Paula L Bockenstedt, Spero R Cataland, et al.
Pageof 3